Derik de Bruin is a Managing Director in US Equity Research covering Life Science and Diagnostic Tools, based in New York. de Bruin joined the firm in 2011. Since 2010, the first year that Life Sciences & Diagnostic Tools was recognized as a category in the annual Institutional Investor All-America Research Survey, de Bruin has ranked in the top three. He previously worked as a senior analyst at UBS, an analyst in biotechnology at Credit Suisse First Boston, and as a research associate in biotechnology at Salomon Smith Barney. de Bruin began his career as a research scientist working as an investigator at Rockefeller University, a postdoctoral fellow at Princeton University, Fred Hutchinson Cancer Research Center, and The Salk Institute, a graduate fellow at Memorial Sloan-Kettering Cancer Center, and a technician at Los Alamos National Laboratory. He has a BS in biology and chemistry from Eastern New Mexico University and a PhD in molecular biology from Cornell University.
Derik de Bruin, PhD
Managing Director, Global Research, BofA Securities